XFOR

X4 Pharmaceuticals, Inc.

1.03 USD
+0.01 (+0.98%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

X4 Pharmaceuticals, Inc. stock is up 7.29% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 June’s closed higher than May. In the last 5 Unusual Options Trades, there were 2 CALLs, 3 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
19 Apr 17:48 17 May, 2024 1.00 CALL 984 4362
26 Apr 16:21 17 May, 2024 1.00 CALL 3051 4183
29 Apr 13:34 17 May, 2024 1.00 PUT 2187 1782
03 May 17:09 17 May, 2024 1.50 PUT 1350 304
03 May 17:09 17 May, 2024 1.50 PUT 1267 304

About X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor. The company is also developing X4P-002, a CXCR4 antagonist for the. treatment of brain cancers.